I nitial models of coagulation postulated a strict separation of the initiator of coagulation, tissue factor (TF), from the coagulation factors in blood. More recent studies have shown low but detectable levels of TF in blood 1 (reviewed in 2 ). This suggests that TF activity is under some level of control beyond simple expression levels.
One mechanism of control is suggested by the observation from cell culture studies that TF activity on cells can be rapidly and substantially increased without significant changes in TF antigen. 3 TF with reduced activity has been referred to as encrypted. The evidence supporting TF encryption and decryption has been dealt with in a previous review. 2 It has been proposed that chemical reactions involving two half-cystines in the extracellular domain of tissue factor, cys 186 and cys 209 , are the key events regulating TF procoagulant and signaling functions. 4 -8 According to the allosteric disulfide bond hypothesis, when the side chains are reduced TF is inactive/encrypted. When the sulfhydryls are oxidized, the resulting disulfide bond formation induces a conformational change that converts TF to a procoagulant/decrypted state. Some of the literature has proposed that protein disulfide isomerase (PDI) is responsible for the oxidation step. 5 After three years there is still no direct quantitative evidence for free thiols in TF. In tissue culture studies, both oxidizing and reducing agents can promote TF decryption. 9 Further, studies on PDI have suggested that lipid contamination of the protein might account for the TF decryption observed in some studies. 10 More problematic is the issue of accessibility. Are the half-cystines available for the proposed redox reactions? This is a relevant question because the half-cystines are buried deep within complex when activated factor VII (FVIIa) binds to the extracellular domain of TF 11 (see Figure) .
Direct binding studies have established that encrypted TF and decrypted TF form stable high-affinity associations with FVII and FVIIa. [12] [13] [14] All the observed dissociation constants are well below the plasma concentration of FVII. Also, there is sufficient extravascular FVII/FVIIa to saturate TF on perivascular cells even in the absence of injury. 15 Finally, during the ionophore-induced conversion of encrypted TF-FVIIa to decrypted TF-FVIIa the enzyme remains bound to the cofactor. 3 This body of evidence supports the conclusion that FVII/FVIIa is bound to essentially all the TF molecules on cells in blood and the surrounding vessel wall. Therefore, cys 186 and cys 209 are not available to interact with PDI or even participate in the proposed reactions.
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Figure.
Disulfide 186 to 209 is masked by FVIIa binding to TF. The left panel shows TF in blue with the cys 186 -cys 209 disulfide shown in yellow. The right panel shows TF in the same orientation with FVIIa shown in red. The model was constructed from the 1DAN submission 11 to the Protein Data Bank 16 using the program Pymol. 17 
